Diabetes
Recent Findings in Diabetes Described by A. Palermo and Colleagues
Published in Obesity and Diabetes Week, February 14th, 2011
2011 FEB 14 -- According to recent research published in the journal Diabetes Obesity & Metabolism, "Postprandial hyperglycaemia is a consequence of reduced first phase insulin response and is associated with increased cardiovascular risk and mortality. The aim of this proof-of-concept study was to investigate the safety and efficacy of treatment with buccal spray insulin (Oral-lyn ™, Generex Biotechnology Corporation, Toronto, Ontario, Canada) on postprandial plasma glucose and insulin levels in subjects with impaired glucose tolerance (IGT)."
"A total of 19 female and 12 male Caucasian subjects, 52.2 +/- 13.5 (SD) years old, having a body...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Proinsulin
Data from University of Thessaloniki, Second Department of Internal Medicine Provide New Insights into Proinsulin - Hemodynamics
Data on Hemodynamics Published by M.J. Carrington and Colleagues - Hypertension
Findings from E. Ritz and Co-Authors Broaden Understanding of Hypertension - Diabetes
New Data from B.H. Kim et al Illuminate Research in Diabetes - Diabetes
New Diabetes Study Findings Recently Were Reported by Researchers at Novartis - Diabetes
New Diabetes Study Results Reported from L. Morrow et al - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
